Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 11
Submit an article Journal homepage
267
Views
6
CrossRef citations to date
0
Altmetric
Original Article: Research

Expression of TRIM28 correlates with proliferation and Bortezomib-induced apoptosis in B-cell non-Hodgkin lymphoma

Pei-Pei ZhangDepartment of Immunity, Medical College, Nantong University, Nantong, P. R. China; View further author information
,
Da-Zhi DingDepartment of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, P. R. China; View further author information
,
Bing ShiDepartment of Oncology, The Second People’s Hospital of Nantong, Nantong, P. R. China; View further author information
,
Shu-Qing ZhangDepartment of Clinical Laboratory, The Second People’s Hospital of Nantong, Nantong, P. R. China; View further author information
,
Ling-Li GuDepartment of Clinical Laboratory, The Second People’s Hospital of Nantong, Nantong, P. R. China; View further author information
,
Yu-Chan WangDepartment of Pathogenic Biology, Medical College, Nantong University, Nantong, P. R. ChinaCorrespondence[email protected]
View further author information
&
Chun ChengDepartment of Immunity, Medical College, Nantong University, Nantong, P. R. China; Correspondence[email protected]
View further author information
 show all
Pages 2639-2649 | Received 05 Oct 2017, Accepted 21 Feb 2018, Published online: 23 Mar 2018

References

  • Ling JY, Sun X, Zhang FX, et al. Dynamic changes of serum proteomic spectra in patients with non-Hodgkin’s lymphoma (NHL) before and after chemotherapy and screening of candidate biomarkers for NHL. Chin J Cancer. 2008;27:1065–1069.
  • Epperla N, Ahn KW, Ahmed S, et al. Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma. J Hematol Oncol. 2017;10:117.
  • Scarfò L, Ghia P. Reprogramming cell death: BCL2 family inhibition in hematological malignancies. Immunol Lett. 2013;155:36–39.
  • Jones JA, Rupert A, Poi M, et al. Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin’s lymphoma. Am J Hematol. 2014;89:19–24.
  • Itokawa Y, Yanagawa T, Yamakawa H, et al. KAP1-independent transcriptional repression of SCAN-KRAB-containing zinc finger proteins. Biochem Biophys Res Commun. 2009;388:689–694.
  • Cheng CT, Kuo CY, Ann DK. KAPtain in charge of multiple missions: emerging roles of KAP1. World J Biol Chem. 2014;5:308–320.
  • Fitzgerald S, Sheehan K, O’Grady M, et al. Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients. J Gastroenterol Hepatol. 2013;28:967.
  • Chen L, Chen DT, Kurtyka C, et al. Tripartite motif containing 28 (TRIM28) can regulate cell proliferation by bridging HDAC1/E2F interactions. J Biol Chem. 2012;287:40106–40118.
  • Hu M, Xin F, Cui Y, et al. Expression of KAP1 in epithelial ovarian cancer and its correlation with drug-resistance. Int J Clin Experiment Med. 2015;8:17308.
  • Litvinov IV, Netchiporouk E, Cordeiro B, et al. Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma. Oncoimmunology. 2014;3:e970025.
  • Arora N, Manipadam M, Nair TS. Frequency and distribution of lymphoma types in a tertiary care hospital in South India: analysis of 5115 cases using the World Health Organization 2008 classification and comparison with world literature. Leuk Lymphoma. 2013;54:1004–1011.
  • Li Z, Tai YT, Ho MZ, et al. Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era. Experiment Hematol Oncol. 2017;6:20.
  • Addison JB, Koontz C, Fugett JH, et al. KAP1 promotes proliferation and metastatic progression of breast cancer cells. Cancer Res. 2015;75:344.
  • Qi Z, Cai S, Cai J, et al. miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro. BMC Neurol. 2016;16:248.
  • Li P, Harris D, Liu Z, et al. STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis. Mol Cancer Res. 2014;12:1267.
  • Yang B, O’Herrin SM, Wu J, et al. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res. 2007;67:9954.
  • Wang C, Ivanov A, Chen L, et al. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J. 2005;24:3279–3290.
  • Saha MN, Chang H. Pharmacological activation of the p53 pathway in haematological malignancies. J Clin Pathol. 2010;63:204.
  • Zenz T, Kreuz M, Fuge M, et al. TP53 mutation and survival in aggressive B cell lymphoma. Int J Cancer. 2017;141:1381–1388.
  • Ramanarayanan J, Czuczman MS. Pro-apoptotic therapy with the oligonucleotide Genasense (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab. Br J Haematol. 2004;127:519–530.
  • Liu L, Zhao E, Li C, et al. TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer. Cancer Epidemiol. 2013;37:71–78.
  • Herquel B, Ouararhni K, Khetchoumian K, et al. Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma. Proc Natl Acad Sci USA. 2011;108:8212.
  • Okamoto K, Kitabayashi I, Taya Y. KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction. Biochem Biophys Res Commun. 2006;351:216–222.
  • Doyle JM, Gao J, Wang J, et al. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell. 2010;39:963.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.